Today

Agents

Chat

Arena

Discover

More

App

Q32 Bio to release 36-week SIGNAL-AA Phase 2a bempikibart data July 13 - QTTB News | Rallies

Q32 Bio to release 36-week SIGNAL-AA Phase 2a bempikibart data July 13

QTTB•2026-07-10

Conference call and webcast

A conference call and webcast to discuss the data is scheduled for 8:00 a.m. ET that day.

Upcoming Phase 2a data release

Q32 Bio will release 36-week topline results from Part B of its SIGNAL-AA Phase 2a trial of bempikibart in severe alopecia areata on July 13, 2026.

Related News

Nasdaq trade halt continues <EMPG.O> reason not available at 03:28 AM

EMPG•2026-07-11

Nasdaq trade halt continues CCHH halt news pending at 03:28 AM

CCHH•2026-07-11

Thrivent Financial for Lutherans sells USD 472,348 of Gloo Holdings common shares

•

2026-07-10

Aterian adjourns shareholder meeting, reschedules vote for July 17

ATER•2026-07-10

Burtech Acquisition II units begin trading separately as shares and warrants July 14 on Nasdaq

BRKHU•2026-07-10